Evidence map›Paper›PMID 28922514›Full record

ArticleOral diseases2018

The complexity of oral physiology and its impact on salivary diagnostics.

E J Helmerhorst, C Dawes, F G Oppenheim

Abstract read
In one paragraph

Article in Oral diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. α1 adrenergic receptors in serum and saliva of patients with oral squamous cell carcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

E J HelmerhorstDepartment of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4803-3018
C DawesDepartment of Oral Biology, University of Manitoba, Winnipeg, MB, Canada.
F G OppenheimDepartment of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA.
Boston University · USUniversity of Manitoba · CA

Funding

Microsensor Arrays for Saliva DiagnosticsU01DE017788 · NIDCR · TUFTS UNIVERSITY MEDFORD · PI WALT, DAVID R. · 2006 to 2010
$8.2M
MICROBICIDAL SALIVARY HISTIDINE-RICH PROTEINSR01DE007652 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI OPPENHEIM, FRANK G · 1986 to 2012
$3.9M
Microsensor Arrays for Saliva DiagnosticsU01DE014950 · NIDCR · TUFTS UNIVERSITY MEDFORD · PI WALT, DAVID R. · 2002 to 2005
$3.8M
Salivary Proteins in Dental IntegumentsR01DE005672 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI OPPENHEIM, FRANK G · 1985 to 2009
$3.1M
Oral microbial enzymes for the treatment of celiac diseaseK02AI101067 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HELMERHORST, EVA JOSEPHINE · 2013 to 2017
$509k
Oral Fluid Proteolytic Effects on Salivary Protein Structure and FunctionR21DE018132 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HELMERHORST, EVA JOSEPHINE · 2008 to 2009
$447k
SALIVARY PROTEINS IN DENTAL INTEGUMENTSR37DE005672 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI OPPENHEIM, FRANK G · 1991 to 2000
$411k
Oral Yeast Carriage and Salivary Antifungal ActivityR03DE016699 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HELMERHORST, EVA JOSEPHINE · 2007 to 2008
$162k
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM--NIGMSF31DE005672 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI MATHURIN, WILLIAM · 1994 to 1997
–
NIAID NIH HHS K02 AI101067NIDCR NIH HHS F31 DE005672NIDCR NIH HHS R01 DE005672NIDCR NIH HHS R01 DE007652NIDCR NIH HHS R03 DE016699NIDCR NIH HHS R21 DE018132NIDCR NIH HHS R37 DE005672NIDCR NIH HHS U01 DE014950NIDCR NIH HHS U01 DE017788
6 · The paper itself

Abstract

objectivesSaliva contains biomarkers for systemic as well as oral diseases. This study was undertaken to assess the variability in the sources of such biomarkers (plasma, cells) and attempted to identify saliva deterioration markers in order to improve saliva diagnostic outcomes. MATERIALS AND

methodsInter- and intrasubject variations in salivary gingival crevicular fluid levels were determined by measuring salivary albumin and transferrin levels. The purity of collected glandular secretions was determined by bacterial culture, and the variability in epithelial cell numbers by cell counting and optical density measurement. Saliva sample deterioration markers were identified by RP-HPLC and LC-ESI-MS/MS.

resultsTenfold variations were observed in plasma-derived albumin and transferrin levels, emphasizing the need for biomarker normalization with respect to plasma contributions to saliva. Epithelial cell levels varied 50-fold in samples collected before and after a meal. Salivary fungal levels varied within subjects and among subjects from 0 to >1,000 colony-forming units per milliliter. In saliva samples incubated for various time intervals at 37°C, five peptides were identified that steadily increased in intensity over time and which could be explored as "deterioration markers."

conclusionTaking saliva characteristics appropriately into account will help realize the promise that this body fluid is suitable to be exploited for reliable healthcare monitoring and surveillance.

Indexed as

AlbuminsBiomarkersEpithelial CellsFungiGingival Crevicular FluidHumansMouthPeptidesPlasmaSalivaTransferrinAlbuminsBiomarkersPeptidesTransferrinalbumindiagnosticgingival fluidplasmaproteasesquality control

Identifiers

PMID28922514
PMCPMC6858792
OpenAlexW2756206630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.